- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05946733
Two Approaches of Transversus Abdominis Block (TAP ) in Laparoscopic Cholecystectomy (TAP)
Comparison Between The Analgesic Effect of Oblique Subcostal and Lateral Approach of Ultrasound-Guided Transverse Abdominis Blocks for Patients Undergoing Laparoscopic Cholecystectomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
General anesthesia induction will be achieved using a sleeping dose of fentanyl 1µg/kg intravascular(IV), propofol 2mg/kg (IV), and atracurium 0.5mg/kg (IV) to facilitate tracheal intubation. General anesthesia will be maintained with lungs ventilation by pressure controlled mode with isoflurane
During anesthesia maintenance Intraoperatively, if blood pressure BP or heart rate (HR) increase more than 20% from baseline, intravenous morphine (3- 5mg) will be given to stabilize the patients' haemodynamics. Fifteen minutes before the end of surgery all patients will receive 1g intravenous paracetamol and 4 grams ondansetron.
Patients will be randomly divided into three equal groups:
Group A: will receive bilateral oblique subcostal TAP block Group B: will receive bilateral lateral TAP block. Group C :will receive postoperative morphine by patient-controlled analgesia (PCA).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sondos Mokhtar Nassar, M.B.,B.C
- Phone Number: 02 01020113426
- Email: sondosnassar945@gmail.com
Study Contact Backup
- Name: Amal Gouda Safan, MD
- Phone Number: 02 01027386221
- Email: AMAL.GODA52@med.menofia.edu.eg
Study Locations
-
-
Shibin Elkom
-
Cairo, Shibin Elkom, Egypt
- Menoufia University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Eligible patients will be older than 21 years old with American society of anaesthesia physical status I& II scheduled for elective laparoscopic cholecystectomy.
Exclusion Criteria:
- - Uncooperative.
- Patients who have allergy to any of the study drugs.
- Patients who are on opioids.
- Known abuse of alcohol or medication.
- Local infection at the site of injection or systemic infection.
- Pregnancy.
- Patients with coagulation disorders or on anticoagulation therapy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group A
subcostal TAP block
|
After induction of general anesthesia, oblique subcostal TAP blocks will be done(14) under the guidance of Sonosite ,superficial probe ,14-15 MHz ultrasound transducer
|
Experimental: Group B
lateral TAP block.
|
After induction of general anesthesia, bilateral lateral TAP block will be performed (15) under ultrasonographic guidance with transportable ultrasound device ( Sonosite ,superficial probe ,14-15 MHz)
|
Other: GroupC
will receive postoperative morphine by patient-controlled analgesia (PCA).
|
the analgesia will be maintained using a morphine patient-controlled analgesia (PCA) device set to give 1.5 mg bolus administration of morphine without a basic rate and 15 min lock-out time.
The total amount of morphine administration will be recorded for the subsequent 24 h
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
opioid consumption
Time Frame: 48 hours
|
milligrams
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
patient satisfaction
Time Frame: 48 hours
|
visual analogue scale ((a scale from 0 to 10 where 0 is interpreted as no pain, 1-4 mild pain, 5-6 moderate pain, 7-10 severe pain)
|
48 hours
|
anesthesia recovery time
Time Frame: 1hour
|
minutes
|
1hour
|
total perioperative analgesics requirements
Time Frame: 24 hours
|
milligrams
|
24 hours
|
Post-operative anaesthetic care unit (PACU) stay
Time Frame: 2 hours
|
minutes
|
2 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: AMAL G SAFAN, MD, Menoufia University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 11/2022ANET10-26
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Opioid Use
-
Sharon WalshNational Institute on Drug Abuse (NIDA)Completed
-
Aurora Health CareUniversity of Chicago; University of California, Santa Cruz; Rogers Behavioral...RecruitingSubstance Use | Methamphetamine-dependence | Opioid Use | Opioid-use Disorder | Cocaine Use Disorder | Cocaine Use | Methamphetamine AbuseUnited States
-
Indonesia UniversityRecruiting
-
Lawson Health Research InstituteNot yet recruiting
-
University of Colorado, DenverUniversity of Nebraska; Agency for Healthcare Research and Quality (AHRQ)Completed
-
Zulekha HospitalsCompleted
-
Peking University People's HospitalCompleted
-
University of UtahCompleted
-
University Health Network, TorontoOntario Ministry of Health and Long Term CareCompleted
Clinical Trials on Group A
-
Riphah International UniversityRecruitingHemiplegic Cerebral PalsyPakistan
-
Dr. Jean-Sebastien Delisle, MD, PhDRecruitingLymphoma | Epstein-Barr Virus Infections | Post-Transplant Lymphoproliferative DisorderCanada
-
Riphah International UniversityCompleted
-
Samsung Medical CenterCompletedEmergencies | Pediatric Disorder | Femoral Artery InjuryKorea, Republic of
-
Riphah International UniversityCompletedAutism Spectrum DisorderPakistan
-
The University of Texas Health Science Center,...National Institute for Occupational Safety and Health (NIOSH/CDC)Completed
-
Kahramanmaras Sutcu Imam UniversityCompletedPain | Interleukin | Vessels; VaricoseTurkey
-
Manuel RodríguezUnknownBrain IschemiaSpain
-
Zhu WeimingRecruiting
-
Oxford University Hospitals NHS TrustUniversity Hospital Southampton NHS Foundation Trust; University Hospital BirminghamCompletedAtrial Fibrillation | Cardiac ArrhythmiaUnited Kingdom